Eupraxia Pharmaceuticals Inc
Institutional coverage
50 13F filers hold $EPRX.
13F holders
50
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
1 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 50 · Source: 13F-HR01
Forvis Mazars Wealth Advisors, LLC
0.18% of portfolio
3,666,465 sh
02
Siguler Guff Advisers, LLC
0.03% of portfolio
2,684,356 sh
03
Northeast Financial Consultants Inc
0.01% of portfolio
1,935,150 sh
04
Human Investing LLC
0.60% of portfolio
1,589,005 sh
05
Mint Tower Capital Management B.V.
0.82% of portfolio
1,350,000 sh
06
Vivo Capital, LLC
0.81% of portfolio
1,350,000 sh
07
Siemens Pension Trust E V
0.01% of portfolio
1,350,000 sh
08
Liberty Wealth Management LLC
0.72% of portfolio
1,214,741 sh
09
Scopia Capital Management LP
2.00% of portfolio
1,200,000 sh
10
Silver Lake Group, L.L.C.
0.34% of portfolio
700,000 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $EPRX in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $EPRX in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 09:15 UTC.